Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Boik

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
BMC Pharmacology|July 31, 2008
A classification model to predict synergism/antagonism of cytotoxic mixtures using protein-drug docking scoresJohn C Boik, Robert A Newman
BMC Pharmacology|June 17, 2008
Structure-activity models of oral clearance, cytotoxicity, and LD50: a screen for promising anticancer compoundsJohn C Boik, Robert A Newman
Statistics in Medicine|September 5, 2007
Quantifying synergism/antagonism using nonlinear mixed-effects modeling: a simulation studyJohn C Boik, Robert A Newman, Robert J Boik
Journal of Biophotonics|February 21, 2012
The need for speedJeffrey L Suhalim, John C Boik, Bruce J Tromberg, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
BMC Pharmacology|July 31, 2008
A classification model to predict synergism/antagonism of cytotoxic mixtures using protein-drug docking scoresJohn C Boik, Robert A Newman
BMC Pharmacology|June 17, 2008
Structure-activity models of oral clearance, cytotoxicity, and LD50: a screen for promising anticancer compoundsJohn C Boik, Robert A Newman
Statistics in Medicine|September 5, 2007
Quantifying synergism/antagonism using nonlinear mixed-effects modeling: a simulation studyJohn C Boik, Robert A Newman, Robert J Boik
Journal of Biophotonics|February 21, 2012
The need for speedJeffrey L Suhalim, John C Boik, Bruce J Tromberg, et al.
Pageof 1